ECCV
Eagle Point Credit Company Inc.
There isn't enough reported data to score ECCV yet.
GS
The Goldman Sachs Group, Inc.
GS's fundamentals are strong: revenue grew 19% and its operating margin rose 4 points to 40%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
ECCV Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
ECCV's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like ECCV.
GS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| N/A | |
| N/A |
GS's revenue and profitability are currently strong. Free cash flow and net leverage aren't meaningful measures for financial services companies like GS.
ECCV PE Valuation
ECCV has no meaningful PE right now: it lost money over the past year.
GS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.6x | $528 | -42% |
| Current | 13x | $914 | — |
| Forward | 13x | $914 | — |
| Fair | 14x | $940 | +2.9% |
| Expensive | 17x | $1,214 | +33% |
Historical ranges are pointers, not guarantees.
GS's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
ECCV Forward outlook
There aren't enough analyst estimates for ECCV to show an outlook.
GS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for GS, with profitability improving. However, they disagree widely on these estimates.
ECCV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.24 | -1227% |
| Q1 2026 | -$1.29 | -$0.89 |
| Q4 2025 | -$0.98 | -217% |
| Q3 2025 | $0.26 | -67% |
| Q2 2025 | $0.11 | -93% |
| Q1 2025 | -$0.40 | -123% |
| Q4 2024 | $0.84 | -50% |
| Q3 2024 | $0.78 | -48% |
ECCV has swung to a loss: it lost $1.24 per share over the past year, after a profit the year before.
GS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $72.35 | +4% |
| Q3 2026 | $69.58 | +41% |
| Q2 2026 | $64.82 | +43% |
| Q1 2026 | $54.75 | +27% |
| Q4 2025 | $51.32 | +27% |
| Q3 2025 | $49.22 | +44% |
| Q2 2025 | $45.37 | +45% |
| Q1 2025 | $43.08 | +68% |
| Q4 2024 | $40.54 | +77% |
GS has the edge over ECCV on earnings quality, reporting a profit while its opponent remains loss making.
ECCV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $31.4M | -45% |
| Q3 2025 | $52M | +10% |
| Q1 2025 | $57.7M | +41% |
| Q4 2024 | $49.5M | +26% |
| Q3 2024 | $47.1M | +31% |
| Q1 2024 | $40.8M | +32% |
| Q4 2023 | $39.4M | +21% |
| Q3 2023 | $36M | +19% |
ECCV's revenue has slid since its 2025 peak: −$63M last quarter, down 188% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -433% | -282 points |
| Q3 2025 | 75% | +1.5 points |
| Q2 2025 | 87% | N/A |
| Q1 2025 | -152% | -220 points |
| Q4 2024 | 65% | -7.4 points |
| Q3 2024 | 73% | +0.9 points |
| Q1 2024 | 69% | -9 points |
| Q4 2023 | 73% | -2.6 points |
ECCV's operating margin was −433% last quarter, down 498 points from the same quarter a year ago, near the bottom of its range since 2019.
GS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $18.7B | +23% |
| Q2 2026 | $20.3B | +39% |
| Q1 2026 | $17.2B | +14% |
| Q4 2025 | $13.5B | -3% |
| Q3 2025 | $15.2B | +20% |
| Q2 2025 | $14.6B | +15% |
| Q1 2025 | $15.1B | +6% |
| Q4 2024 | $13.9B | +23% |
GS has the edge over ECCV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +2 points |
| Q2 2026 | 42% | +8.1 points |
| Q1 2026 | 38% | +0.2 points |
| Q4 2025 | 44% | +5.6 points |
| Q3 2025 | 36% | +4.1 points |
| Q2 2025 | 34% | +3.2 points |
| Q1 2025 | 37% | +0.6 points |
| Q4 2024 | 38% | +18 points |
GS's operating margin was 37% last quarter, up 2 points from the same quarter a year ago.
ECCV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $34.8M | +17% |
| Q1 2026 | $29M | +6% |
| Q4 2025 | $30.3M | +24% |
| Q3 2025 | -$16.3M | -158% |
| Q2 2025 | $29.7M | +3.2% |
| Q1 2025 | $27.4M | +24% |
| Q4 2024 | $24.5M | +2% |
| Q3 2024 | $28.2M | +27% |
ECCV has the edge over GS on cash generation, producing positive trailing cash flow while its opponent burns cash.
GS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +72% |
| Q2 2026 | $5.6B | +7.8% |
| Q1 2026 | -$32.4B | +$5.3B |
| Q4 2025 | -$16.8B | -136% |
| Q3 2025 | $2.1B | +$40.6B |
| Q2 2025 | $5.2B | -6.8% |
| Q1 2025 | -$37.7B | -$9.2B |
| Q4 2024 | $46.2B | +$75.1B |
GS's free cash flow was −$40B over the past year, against $15.8B the year before. Free cash flow isn't a meaningful measure for financial services companies like GS.
ECCV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +480K shares |
| 1 year | +11% | +12.8M shares |
| 3 years | +112% | +70.2M shares |
| 5 years | +286% | +98.5M shares |
| Available history | +390% | +106M shares |
ECCV has 133M diluted shares, up 11% from a year ago, despite $63M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $57.9M |
| Q1 2026 | $4.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
ECCV spent $63M buying back its own shares over the past year, after none the year before.
GS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.2% | -3.8M shares |
| 1 year | -4.4% | -13.9M shares |
| 3 years | -12% | -42.8M shares |
| 5 years | -15% | -52.8M shares |
| Available history | -20% | -74.4M shares |
GS has the edge over ECCV on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3B |
| Q2 2026 | $4B |
| Q1 2026 | $5B |
| Q4 2025 | $3B |
| Q3 2025 | $2B |
| Q2 2025 | $3B |
| Q1 2025 | $4.4B |
| Q4 2024 | $2B |
GS spent $15B buying back its own shares over the past year, up 32% from the year before.
ECCV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | 7.6x | High |
| Q2 2025 | 4.8x | High |
| Q1 2024 | 1.8x | Healthy |
| Q4 2023 | 1.1x | Healthy |
| Q3 2023 | 1.8x | Healthy |
| Q2 2023 | 1.2x | Healthy |
| Q1 2023 | 2.1x | Moderate |
| Q4 2022 | 1.1x | Healthy |
ECCV's net debt is about 7.6 years of its operating earnings (EBITDA), up from 1.8 years a year ago. Net leverage isn't a meaningful measure for financial services companies like ECCV.
GS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.4x | Net Cash |
| Q2 2026 | -6.1x | Net Cash |
| Q1 2026 | -6.7x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -3.5x | Net Cash |
| Q2 2025 | -3.1x | Net Cash |
| Q1 2025 | -3.9x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
GS has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like GS.
ECCV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.4 | Neutral |
| Stochastic | 43.3 | Neutral |
ECCV's weekly RSI is 52 (neutral) and its Stochastic is 43 (neutral).
GS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 16.3 | Oversold |
GS's weekly RSI is 45 (neutral) and its Stochastic is 16 (oversold).
ECCV PE vs Financial Services Sector
| Metric | ECCV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ECCV has no meaningful PE right now: it lost money over the past year.
GS PE vs Financial Services Sector
| Metric | GS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 13x | 0.8% above |
| PE % | 46 | 63 | 17 pts below |
GS is trading at 13x earnings, in line with the Financial Services sector's median of 13x, though its earnings don't support one.
ECCV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $24.2 | 0.1% below |
| 20 week MA | $24.1 | 0.2% above |
| 50 week MA | $23.9 | 1.1% above |
| 100 week MA | $23.5 | 2.8% above |
| 200 week MA | $22.9 | 5.6% above |
ECCV has the edge over GS on trend strength, trading above more of its moving averages.
GS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $895.5 | 2% above |
| 20 week MA | $977.4 | 6.5% below |
| 50 week MA | $945.4 | 3.4% below |
| 100 week MA | $804.5 | 14% above |
| 200 week MA | $602.7 | 52% above |
GS's trend is mixed: it's above three of its five weekly moving averages, and 52% above its 200-week average.
ECCV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $24.3 | $21.0 | -13% |
| 2023 | $21.0 | $22.4 | +6.4% |
| 2024 | $22.4 | $22.7 | +1.6% |
| 2025 | $22.7 | $23.5 | +3.5% |
| 2026 YTD | $23.5 | $24.2 | +2.8% |
ECCV has the edge over GS on returns for 2026, with the stronger performance.
GS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $230.7 | $256.2 | +11% |
| 2021 | $256.2 | $385.0 | +50% |
| 2022 | $385.0 | $345.5 | -10% |
| 2023 | $345.5 | $385.8 | +12% |
| 2024 | $385.8 | $576.2 | +49% |
| 2025 | $576.2 | $907.0 | +57% |
| 2026 YTD | $907.0 | $913.6 | +0.7% |
GS has finished higher in five of the last six years, two of them by more than 50%. It's up 0.7% so far in 2026.